What is Maolac?
Maolac operates at the intersection of biotechnology and advanced nutrition, specializing in the development of biofunctional proteins inspired by the composition of human breast milk. By utilizing bovine colostrum, the company has engineered products such as Super Colostrum and Maolactin, which are clinically validated to support gut health, muscle recovery, and systemic wellness. The company's core value proposition lies in its heat-stable, versatile formulations that allow for seamless integration into diverse consumer formats, including gummies and powders. This technological edge positions Maolac as a disruptive force in the health-conscious consumer sector, effectively bridging the gap between traditional supplementation and precision nutrition.
How much funding has Maolac raised?
Maolac has raised a total of $3.2M across 1 funding round:
Angel/Seed
$3.2M
Angel/Seed (2022): $3.2M with participation from The Food Tech Lab, The Kitchen FoodTech H, and OurCrowd
Key Investors in Maolac
The Food Tech Lab
An innovation hub and investment entity focused on accelerating the development of next-generation food technologies and sustainable nutrition solutions.
The Kitchen FoodTech H
A specialized food-tech incubator and investment firm dedicated to fostering startups that address global food system challenges through scientific innovation.
OurCrowd
A prominent global venture investment platform that provides accredited investors and institutions access to early-stage startups and venture funds.
What's next for Maolac?
With the recent influx of financing, Maolac is poised to accelerate its research and development pipeline while simultaneously scaling its manufacturing capabilities to meet rising global demand. The strategic roadmap likely involves deepening market penetration among athletes and the aging population, two demographics where the demand for clinically backed, high-absorption nutritional solutions is surging. Furthermore, the company is expected to leverage this capital to strengthen its intellectual property portfolio and expand its distribution networks. By focusing on operational efficiency and product diversification, Maolac aims to solidify its market position as a leader in the functional protein space, potentially setting the stage for future institutional partnerships or further rounds of growth-stage financing.
See full Maolac company page
